Decreased PSA Nadir as a Result of Dose-Escalated Stereotactic Body Radiation for Patients With Low- and Intermediate-Risk Prostate Cancer

被引:0
|
作者
Rana, Zaker [1 ]
Potters, Louis [1 ]
Lee, Lucille [1 ]
Cox, Brett [1 ]
机构
[1] Zucker Sch Med Hofstra Northwell, Dept Radiat Med, Hempstead, NY USA
关键词
D O I
10.1016/j.ijrobp.2018.02.108
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P20
引用
收藏
页码:E28 / E29
页数:2
相关论文
共 50 条
  • [1] Decreased PSA nadir as a result of dose-escalated stereotactic body radiation for patients with low- and intermediate-risk prostate cancer.
    Rana, Zaker Hamid
    Potters, Louis
    Lee, Lucille
    Cox, Brett W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Dose-Escalated Stereotactic Body Radiation Improves Outcomes in Patients with Low- and Intermediate-Risk Prostate Cancer
    Cox, B. W.
    Rana, Z.
    Lee, L.
    Potters, L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E105 - E105
  • [3] Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase 1 Trial for Patients With Low- and Intermediate-Risk Prostate Cancer
    Potters, Louis
    Rana, Zaker
    Lee, Lucille
    Cox, Brett W.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 104 (02): : 334 - 342
  • [4] Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase I/II Trial for Patients With Low- and Intermediate-Risk Prostate Cancer
    Rana, Zaker
    Potters, Louis
    Lee, Lucille
    Cox, Brett
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 101 (02): : E8 - E8
  • [5] Dose-Escalated Radiation Therapy for Intermediate-Risk Prostate Cancer
    Liauw, Stanley L.
    Fricano, Janine
    Correa, David
    Weichselbaum, Ralph R.
    Jani, Ashesh B.
    [J]. CANCER, 2009, 115 (08) : 1784 - 1790
  • [6] Stereotactic Body Radiotherapy for Low- and Intermediate-Risk Prostate Cancer
    Kishan, Amar U.
    King, Christopher R.
    [J]. SEMINARS IN RADIATION ONCOLOGY, 2017, 27 (03) : 268 - 278
  • [7] Stereotactic Body Radiation Therapy for Low- to Intermediate-risk Prostate Adenocarcinoma
    Jeong, Bae-Kwon
    Jeong, Hojin
    Ha, In Bong
    Choi, Hoon Sik
    Kam, Sung Chul
    Hwa, Jeong Seok
    Hyun, Jae Seog
    Chung, Ky Hyun
    Choi, See Min
    Kang, Ki Mun
    [J]. JOURNAL OF KOREAN MEDICAL SCIENCE, 2015, 30 (06) : 710 - 715
  • [8] Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer
    Nguyen, Kevin A.
    Lee, Alan
    Patel, Sagar A.
    Chakravorty, Arun
    Yu, James B.
    Kishan, Amar U.
    Chang, Albert J.
    [J]. JAMA NETWORK OPEN, 2020, 3 (09)
  • [9] Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer
    Bremer, M.
    [J]. STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (02) : 192 - 193
  • [10] Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer
    Boike, Thomas P.
    Lotan, Yair
    Cho, L. Chinsoo
    Brindle, Jeffrey
    DeRose, Paul
    Xie, Xian-Jin
    Yan, Jingsheng
    Foster, Ryan
    Pistenmaa, David
    Perkins, Alida
    Cooley, Susan
    Timmerman, Robert
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15) : 2020 - 2026